Evidence map›Paper›PMID 26197338›Full record

ArticleToxins2015

Biochemical Characterization of a Recombinant UDP-glucosyltransferase from Rice and Enzymatic Production of Deoxynivalenol-3-O-β-D-glucoside.

Herbert Michlmayr, Alexandra Malachová, Elisabeth Varga, Jana Kleinová, Marc Lemmens, Sean Newmister, Ivan Rayment, Franz Berthiller, Gerhard Adam

Open access · goldAbstract read
In one paragraph

Article in Toxins, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
10.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. A Novel Deoxynivalenol-Activated WheatJournal of fungi (Basel, Switzerland) · 2021
    Article
  10. Article
  11. Review
  12. Toxins · 2019
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Herbert MichlmayrDepartment of Applied Genetics and Cell Biology, University of Natural Resources and Life Sciences, Vienna (BOKU), Konrad Lorenz Str. 24, 3430 Tulln, Austria. herbert.michlmayr@boku.ac.at.
Alexandra MalachováChristian Doppler Laboratory for Mycotoxin Metabolism and Center for Analytical Chemistry, Department of Agrobiotechnology (IFA-Tulln), BOKU, Konrad Lorenz Str. 20, 3430 Tulln, Austria. alexandra.malachova@boku.ac.at.
Elisabeth VargaChristian Doppler Laboratory for Mycotoxin Metabolism and Center for Analytical Chemistry, Department of Agrobiotechnology (IFA-Tulln), BOKU, Konrad Lorenz Str. 20, 3430 Tulln, Austria. elisabeth.varga@boku.ac.at.
Jana KleinováChristian Doppler Laboratory for Mycotoxin Metabolism and Center for Analytical Chemistry, Department of Agrobiotechnology (IFA-Tulln), BOKU, Konrad Lorenz Str. 20, 3430 Tulln, Austria. kleinovaja@seznam.cz.
Marc LemmensBiotechnology in Plant Production, Department IFA-Tulln, BOKU, Konrad Lorenz Str. 20, 3430 Tulln, Austria. marc.lemmens@boku.ac.at.
Sean NewmisterDepartment of Biochemistry, University of Wisconsin, 433 Babcock Dr., Madison, WI 53706, USA. snewmist@umich.edu.
Ivan RaymentDepartment of Biochemistry, University of Wisconsin, 433 Babcock Dr., Madison, WI 53706, USA. ivan_rayment@biochem.wisc.edu.
Franz BerthillerChristian Doppler Laboratory for Mycotoxin Metabolism and Center for Analytical Chemistry, Department of Agrobiotechnology (IFA-Tulln), BOKU, Konrad Lorenz Str. 20, 3430 Tulln, Austria. franz.berthiller@boku.ac.at.
Gerhard AdamDepartment of Applied Genetics and Cell Biology, University of Natural Resources and Life Sciences, Vienna (BOKU), Konrad Lorenz Str. 24, 3430 Tulln, Austria. gerhard.adam@boku.ac.at.
Christian Doppler Laboratory for Thermoelectricity · ATBOKU University · ATUniversity of Wisconsin–Madison · USUniversitätsklinikum Tulln · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glycosylation is an important plant defense mechanism and conjugates of Fusarium mycotoxins often co-occur with their parent compounds in cereal-based food and feed. In case of deoxynivalenol (DON), deoxynivalenol-3-O-β-D-glucoside (D3G) is the most important masked mycotoxin. The toxicological significance of D3G is not yet fully understood so that it is crucial to obtain this compound in pure and sufficient quantities for toxicological risk assessment and for use as an analytical standard. The aim of this study was the biochemical characterization of a DON-inactivating UDP-glucosyltransferase from rice (OsUGT79) and to investigate its suitability for preparative D3G synthesis. Apparent Michaelis constants (Km) of recombinant OsUGT79 were 0.23 mM DON and 2.2 mM UDP-glucose. Substrate inhibition occurred at DON concentrations above 2 mM (Ki = 24 mM DON), and UDP strongly inhibited the enzyme. Cu2+ and Zn2+ (1 mM) inhibited the enzyme completely. Sucrose synthase AtSUS1 was employed to regenerate UDP-glucose during the glucosylation reaction. With this approach, optimal conversion rates can be obtained at limited concentrations of the costly co-factor UDP-glucose. D3G can now be synthesized in sufficient quantity and purity. Similar strategies may be of interest to produce β-glucosides of other toxins.

Indexed as

Chromatography, High Pressure LiquidEscherichia coliGlucosidesGlucosyltransferasesGlycosylationOryzaRecombinant ProteinsTandem Mass SpectrometryTrichothecenesdeoxynivalenoldeoxynivalenol-3-glucosideGlucosidesGlucosyltransferasesRecombinant ProteinsTrichothecenesFusariumglycosylationmasked mycotoxinsucrose synthaseUDP-glucose recycling

Identifiers

PMID26197338
PMCPMC4516937
OpenAlexW1527164944

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.